ABIVAX Announces R&D Day at Company’s New
Collaborative Laboratory in Montpellier
- Company to Highlight Broad Product Pipeline
- R&D Day Event to be Webcasted
Paris, October 11th, 2016 – ABIVAX (Euronext Paris: FR0012333284 – ABVX), an innovative biotechnology company targeting the immune system to eliminate viral disease, announces that today it is hosting an R&D Day at the Company’s new collaborative laboratory with the French National Center for Scientific Research (CNRS) in Montpellier.
Inaugurated on September 22nd 2016, this collaborative lab houses all of ABIVAX’s research activities on the Languedoc-Roussillon CNRS campus and is equipped with cutting-edge technological infrastructures and platforms.
+ 33 6 64 18 99 59 or
+ 33 1 44 54 36 65
Standard: +33 1 53 83 08 41